Furthermore, the qPCR experiment (Fig. 1E) of glioma patients (WHO II–IV grade) showed that PVT1 was the highest in WHO IV patients and lowest in WHO II patients (p < 0.0001). The gene discussed is PVT1; the disease is central nervous system cancer.